These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17639816)

  • 1. [Rescue therapy in lupus nephritis patients with mycophenolate mofetil].
    Pretini VB; Avila López GE; Sesín AM; Dotto BH; Sanchez Freytes M; Sesín J; Vergottini JC
    Rev Fac Cien Med Univ Nac Cordoba; 2006; 63(3):39-46. PubMed ID: 17639816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction therapies for class IV lupus nephritis with non-inflammatory necrotizing vasculopathy: mycophenolate mofetil or intravenous cyclophosphamide.
    Wang J; Hu W; Xie H; Zhang H; Chen H; Zeng C; Liu Z; Li L
    Lupus; 2007; 16(9):707-12. PubMed ID: 17728363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective multicentre study of mycophenolate mofetil combined with prednisolone as induction therapy in 213 patients with active lupus nephritis.
    F L; Y T; X P; L W; H W; Z S; H Z; Z H;
    Lupus; 2008 Jul; 17(7):622-9. PubMed ID: 18625634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of pulse intravenous cyclophosphamide versus mycophenolate mofetil in the induction therapy of proliferative lupus nephritis.
    Ong LM; Hooi LS; Lim TO; Goh BL; Ahmad G; Ghazalli R; Teo SM; Wong HS; Tan SY; Shaariah W; Tan CC; Morad Z
    Nephrology (Carlton); 2005 Oct; 10(5):504-10. PubMed ID: 16221103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multitarget therapy of mycophenolate mofetil and cyclosporine A for induction treatment of refractory lupus nephritis.
    Jesus D; Rodrigues M; da Silva JAP; Inês L
    Lupus; 2018 Jul; 27(8):1358-1362. PubMed ID: 29448882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of lupus nephritis by mycophenolate mofetil.
    Rabrenović V; Poskurica M; Kovacević Z; Nesić V; Savin M; Mitić B; Dimković N; Cucković C; Vujić D; Pljesa S; Perunicić-Peković G; Curić S; Mitić I; Ratković M; Marinković J; Jovanović D
    Kidney Blood Press Res; 2010; 33(4):297-303. PubMed ID: 20664209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis.
    Radhakrishnan J; Moutzouris DA; Ginzler EM; Solomons N; Siempos II; Appel GB
    Kidney Int; 2010 Jan; 77(2):152-60. PubMed ID: 19890271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remission of severe relapsing or persistent lupus nephritis using mycophenolate mofetil.
    Flores-Suárez LF
    Arch Med Res; 2006 Jan; 37(1):68-73. PubMed ID: 16314189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis.
    Kasitanon N; Fine DM; Haas M; Magder LS; Petri M
    Lupus; 2006; 15(6):366-70. PubMed ID: 16830883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis.
    Chan TM; Tse KC; Tang CS; Mok MY; Li FK;
    J Am Soc Nephrol; 2005 Apr; 16(4):1076-84. PubMed ID: 15728784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of mycophenolate mofetil for patients with crescentic lupus nephritis.
    Tang Z; Yang G; Yu C; Yu Y; Wang J; Hu W; Zeng C; Chen H; Liu Z; Li L
    Nephrology (Carlton); 2008 Dec; 13(8):702-7. PubMed ID: 18771470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to combination of mycophenolate mofetil, cyclosporin A and corticosteroid treatment in lupus nephritis patients with persistent proteinuria.
    Kasitanon N; Boripatkosol P; Louthrenoo W
    Int J Rheum Dis; 2018 Jan; 21(1):200-207. PubMed ID: 28901731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The safety and efficacy of MMF in lupus nephritis: a pilot study.
    Kingdon EJ; McLean AG; Psimenou E; Davenport A; Powis SH; Sweny P; Burns A
    Lupus; 2001; 10(9):606-11. PubMed ID: 11678448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate mofetil as the primary treatment of membranous lupus nephritis with and without concurrent proliferative disease: a retrospective study of 29 cases.
    Kasitanon N; Petri M; Haas M; Magder LS; Fine DM
    Lupus; 2008 Jan; 17(1):40-5. PubMed ID: 18089682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Manifestation of diffuse proliferative lupus nephritis in a patient treated with long-term mycophenolate mofetil].
    Sixdorf U; Bauer H; Märker-Hermann E
    Dtsch Med Wochenschr; 2006 Oct; 131(41):2266-9. PubMed ID: 17036267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mycophenolate mofetil maintenance therapy in lupus nephritis].
    Milewski M; Jakieła B; Zółciński M; Chmielewska A; Musiał J
    Pol Arch Med Wewn; 2006 Oct; 116(4):947-54. PubMed ID: 18416296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials.
    Zhu B; Chen N; Lin Y; Ren H; Zhang W; Wang W; Pan X; Yu H
    Nephrol Dial Transplant; 2007 Jul; 22(7):1933-42. PubMed ID: 17405792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes--mycophenolate mofetil treatment for lupus nephritis with addition of tacrolimus for resistant cases.
    Cortés-Hernández J; Torres-Salido MT; Medrano AS; Tarrés MV; Ordi-Ros J
    Nephrol Dial Transplant; 2010 Dec; 25(12):3939-48. PubMed ID: 20538787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil for remission induction in severe lupus nephritis.
    Cross J; Dwomoa A; Andrews P; Burns A; Gordon C; Main J; Mathieson P; O'Donoghue D; Jayne D;
    Nephron Clin Pract; 2005; 100(3):c92-100. PubMed ID: 15824513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lupus nephritis: treatment with mycophenolate mofetil.
    Kapitsinou PP; Boletis JN; Skopouli FN; Boki KA; Moutsopoulos HM
    Rheumatology (Oxford); 2004 Mar; 43(3):377-80. PubMed ID: 14963204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.